FDA Details Clinical Trial Criteria For Combo Drugs
The U.S. Food and Drug Administration on Thursday finalized guidance on when and how drugs intended for combination therapy can be tested together in support of joint approval, saying such efforts...To view the full article, register now.
Already a subscriber? Click here to view full article